Financhill
Sell
41

YI Quote, Financials, Valuation and Earnings

Last price:
$0.87
Seasonality move :
25.31%
Day range:
$0.74 - $0.90
52-week range:
$0.55 - $1.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.04x
P/B ratio:
--
Volume:
183.5K
Avg. volume:
155.3K
1-year change:
-41.14%
Market cap:
$75.4M
Revenue:
$2.1B
EPS (TTM):
-$0.44

Analysts' Opinion

  • Consensus Rating
    111 has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of --, 111 has an estimated upside of 582.29% from its current price of $0.88.
  • Price Target Downside
    According to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $0.88.

Fair Value

  • According to the consensus of 0 analysts, 111 has 582.29% upside to fair value with a price target of -- per share.

YI vs. S&P 500

  • Over the past 5 trading days, 111 has overperformed the S&P 500 by 8.12% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • 111 does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • 111 revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter 111 reported revenues of $502.9M.

Earnings Growth

  • 111 has grown year-over-year earnings for 0 quarters straight. In the most recent quarter 111 reported earnings per share of -$0.03.
Enterprise value:
150.1M
EV / Invested capital:
2.21x
Price / LTM sales:
0.04x
EV / EBIT:
--
EV / Revenue:
0.07x
PEG ratio (5yr expected):
-0.07x
EV / Free cash flow:
10.09x
Price / Operating cash flow:
5.06x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$117.2M
Return On Assets:
-8.36%
Net Income Margin (TTM):
-1.74%
Return On Equity:
-89.07%
Return On Invested Capital:
-47.45%
Operating Margin:
0.07%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $2B $2.1B $2B $506.5M $502.9M
Gross Profit $120.8M $126.2M $117.2M $26.3M $29.4M
Operating Income -$56.3M -$35.4M -$27.4M -$11.1M $331.2K
EBITDA -$55.3M -$33M -$25.6M -$10.8M $608K
Diluted EPS -$0.76 -$0.60 -$0.44 -$0.15 -$0.03
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $379.6M $431.1M $391.8M $437.8M $411.7M
Total Assets $398.6M $483.9M $428.7M $460.6M $432.1M
Current Liabilities $259.2M $314.7M $316.9M $408.6M $377.9M
Total Liabilities $267.4M $339.9M $333M $417.4M $388.2M
Total Equity $131.2M $143.9M $95.7M $43.2M $43.9M
Total Debt $26.2M $17.1M $32.2M $47.9M $24M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -$61.4M -$25.4M $14.9M $6.1M $15.5M
Cash From Investing $39.3M -$4.7M $8.7M $323.7K $6.9M
Cash From Financing $29.5M $31.5M -$50.8M $14.8M -$15.6M
Free Cash Flow -$61.4M -$25.4M $14.9M $6.1M $15.5M
YI
Sector
Market Cap
$75.4M
$348.1M
Price % of 52-Week High
47.57%
73.74%
Dividend Yield
0%
0%
Shareholder Yield
--
2.64%
1-Year Price Total Return
-41.14%
-12.75%
Beta (5-Year)
0.414
0.504
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $0.80
200-day SMA
Sell
Level $0.98
Bollinger Bands (100)
Buy
Level 0.66 - 0.96
Chaikin Money Flow
Sell
Level -12.3M
20-day SMA
Buy
Level $0.77
Relative Strength Index (RSI14)
Buy
Level 59.90
ADX Line
Buy
Level 10.88
Williams %R
Sell
Level -11.0255
50-day SMA
Buy
Level $0.76
MACD (12, 26)
Buy
Level 0.02
25-day Aroon Oscillator
Buy
Level 16
On Balance Volume
Sell
Level -12.2M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.0354)
Sell
CA Score (Annual)
Level (-2.1385)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (4.0285)
Sell
Piotroski F Score (Annual)
Level (3)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (2)

Revenue Forecast

Earnings per Share Forecast

Company Profile

111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People’s Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

Stock Forecast FAQ

In the current month, YI has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The YI average analyst price target in the past 3 months is --.

  • Where Will 111 Stock Be In 1 Year?

    According to analysts, the consensus estimate is that 111 share price will rise to -- per share over the next 12 months.

  • What Do Analysts Say About 111?

    Analysts are divided on their view about 111 share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that 111 is a Sell and believe this share price will drop from its current level to --.

  • What Is 111's Price Target?

    The price target for 111 over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is YI A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for 111 is a Buy. 0 of 0 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of YI?

    You can purchase shares of 111 via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase 111 shares.

  • What Is The 111 Share Price Today?

    111 was last trading at $0.87 per share. This represents the most recent stock quote for 111. Yesterday, 111 closed at $0.88 per share.

  • How To Buy 111 Stock Online?

    In order to purchase 111 stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock